The Impact of Hepatitis C Diagnosis on Substance-Use Behaviors in Patients Engaged in Opioid Substitution Therapy – HCV screening/diagnosis reduces drug use by 33% (non-prescribed opioids, benzodiazepines and cocaine) – AASLD
Access article here: http://www.natap.org/2017/AASLD/AASLD_22.htm